RIHAWI, KARIM
 Distribuzione geografica
Continente #
NA - Nord America 903
AS - Asia 862
EU - Europa 793
AF - Africa 91
SA - Sud America 39
OC - Oceania 2
Totale 2.690
Nazione #
US - Stati Uniti d'America 889
IT - Italia 337
CN - Cina 278
SG - Singapore 254
VN - Vietnam 151
DE - Germania 91
GB - Regno Unito 89
HK - Hong Kong 77
SE - Svezia 66
IN - India 41
IE - Irlanda 39
NL - Olanda 35
KR - Corea 29
SC - Seychelles 27
TG - Togo 27
BR - Brasile 26
FR - Francia 23
RU - Federazione Russa 21
BG - Bulgaria 19
FI - Finlandia 19
CI - Costa d'Avorio 16
CH - Svizzera 15
JO - Giordania 12
ID - Indonesia 10
UA - Ucraina 9
ZA - Sudafrica 9
AT - Austria 7
CA - Canada 7
EE - Estonia 7
BE - Belgio 6
JP - Giappone 6
NG - Nigeria 6
AR - Argentina 5
MX - Messico 5
EC - Ecuador 3
PL - Polonia 3
AU - Australia 2
CD - Congo 2
ES - Italia 2
ET - Etiopia 2
LT - Lituania 2
PA - Panama 2
PY - Paraguay 2
TW - Taiwan 2
AL - Albania 1
AM - Armenia 1
CL - Cile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EG - Egitto 1
GR - Grecia 1
PE - Perù 1
UZ - Uzbekistan 1
Totale 2.690
Città #
Singapore 167
Ashburn 130
Bologna 104
Chandler 85
Hong Kong 74
Santa Clara 71
Fairfield 68
Southend 67
Hefei 61
Houston 45
Beijing 44
Woodbridge 44
Dublin 39
Seattle 37
Dong Ket 34
Seoul 29
Wilmington 29
Hanoi 28
Princeton 28
Lomé 27
Boardman 24
Cambridge 23
Florence 21
Sofia 19
Ho Chi Minh City 18
Vicenza 18
Abidjan 16
Milan 16
Bern 15
Los Angeles 15
Helsinki 14
New York 13
Turin 13
Amman 12
Dallas 12
Redondo Beach 10
Shanghai 10
Redmond 9
Berlin 8
Bremen 8
Falkenstein 8
Jinan 8
Westminster 8
Ann Arbor 7
Forlì 7
Munich 7
Nanjing 7
Rimini 7
Rome 7
Abeokuta 6
Brussels 6
Jakarta 6
Tianjin 6
Tokyo 6
Amsterdam 5
Bengaluru 5
Buffalo 5
Frankfurt am Main 5
Hebei 5
Nuremberg 5
San Diego 5
Shenyang 5
Vienna 5
Visakhapatnam 5
Boydton 4
Falls Church 4
Fuzhou 4
Haiphong 4
Hangzhou 4
London 4
Modena 4
Padova 4
Wuhan 4
Boston 3
Bühl 3
Carpi 3
Changsha 3
Ferrara 3
Medford 3
Naples 3
Ninh Bình 3
Paris 3
Redwood City 3
Reggio Emilia 3
San Francisco 3
Shijiazhuang 3
São Paulo 3
Thái Nguyên 3
Turku 3
Warsaw 3
Arzano 2
Cesena 2
Chicago 2
Council Bluffs 2
Curitiba 2
Da Nang 2
Dearborn 2
Des Moines 2
Düsseldorf 2
Formigine 2
Totale 1.758
Nome #
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary 213
A phase II, open-label, single arm, trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale 200
Automated Prediction of the Response to Neoadjuvant Chemoradiotherapy in Patients Affected by Rectal Cancer 190
A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products. 180
Arterial Embolization During Programmed Death-1 Inhibitor Treatment: An Unexpected Finding 173
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer 169
Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies 168
Pembrolizumab in the treatment of metastatic non-small cell lung cancer: A review of current evidence 158
Co-alteration of c-Met and ROS1 in Advanced NSCLC: ROS1 Wins 150
MYC Amplification as a Potential Mechanism of Primary Resistance to Crizotinib in ALK-Rearranged Non-Small Cell Lung Cancer: A Brief Report 150
Chemotherapy treatment in malignant pleural mesothelioma: A difficult history 143
BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience 124
Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study 116
Expected and non-expected immune-related adverse events detectable by CT 112
Emerging therapies in malignant pleural mesothelioma 106
Pneumatosis intestinalis and spontaneous perforation associated with drug toxicity in oncologic patients: A case series 101
IL-1 Associated Post Senescence Reprogramming Impairs Response To EGFR Neutralization 95
Tumor-associated macrophages and inflammatory microenvironment in gastric cancer: Novel translational implications 90
Novel HER2-directed treatments in advanced gastric carcinoma: Another paradigm shift? 80
The safety and efficacy of enzalutamide in the treatment of advanced prostate cancer 37
Immune checkpoint inhibition in small cell lung cancer: A key to reach an unmet need? 34
Totale 2.789
Categoria #
all - tutte 8.529
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.529


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021142 0 0 0 0 0 6 12 8 13 9 15 79
2021/2022221 7 2 7 4 17 16 5 27 16 19 60 41
2022/2023537 21 54 12 56 49 68 30 35 88 13 66 45
2023/2024182 16 22 15 15 19 40 5 6 10 21 6 7
2024/2025655 12 78 51 47 102 48 67 43 12 40 49 106
2025/2026654 166 144 96 87 129 32 0 0 0 0 0 0
Totale 2.789